Thin basement membrane disease historical perspective

Jump to navigation Jump to search

Thin basement membrane disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thin basement membrane disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thin basement membrane disease historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thin basement membrane disease historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thin basement membrane disease historical perspective

CDC on Thin basement membrane disease historical perspective

Thin basement membrane disease historical perspective in the news

Blogs on Thin basement membrane disease historical perspective

Directions to Hospitals Treating Thin basement membrane disease

Risk calculators and risk factors for Thin basement membrane disease historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

Overview

Thin basement membrane disease is the most common cause of Persistent recurrent hematuria. A form of Benign hemorrhagic nephritis is first noted in 1926 by Goerge Baehr. ThenPersistent recurrent hematuria is first observed in seven out of eight siblings in a family by Melvin I. Marks and Keith N. Drummond in 1969. P. W. Rogers was the first one to analyse the association between recurrent asymptomatic hematuria and thin glomerular basement membrane in 1973. The association between the COL4A3, COL4A4 and COL4A5 gene mutation in long q arm of chromosome 2 and the recurrence of X-linked and autosomal alport syndrome in several studies conducted in 1990-1994. In 1996, it was demonstrated that the cause of Benign familial hematuria is Mutation in COL4A3 and COL4A4.

Thin basement membrane disease historical perspective|Historical Perspective

Thin basement membrane disease is the most common cause of Persistent recurrent hematuria besides other cause for example alport syndrome or IgA nephropathy. A form of Benign hemorrhagic nephritis is first noted in 1926 by Goerge Baehr.[1] In 1969, Melvin I. Marks and Keith N. Drummond published an article showing that seven out of eight siblings were having persistent hematuria for 6 months to 8 years duration without experiencing any symptoms. They did not find any abnormalities in renal biopsy, light microscopy, immunofluoroscence. [2] Then P. W. Rogers used electron microscopy to analyse the association between recurrent asymptomatic hematuria and thin glomerular basement membrane is discovered in 1973. [3] From 1990-1994 several studies were conducted to find out the association between the COL4A3, COL4A4 and COL4A5 gene mutation in long q arm of chromosome 2 and the recurrence of X-linked and autosomal alport syndrome.[4] [5] [6][1] Mutation in COL4A3 and COL4A4 was found to cause Benign familial hematuria in 1996.[7]

References

  1. 1.0 1.1 Baehr, George (1926). "A BENIGN AND CURABLE FORM OF HEMORRHAGIC NEPHRITIS". JAMA: The Journal of the American Medical Association. 86 (14): 1001. doi:10.1001/jama.1926.02670400011006. ISSN 0098-7484.
  2. Marks MI, Drummond KN (October 1969). "Benign familial hematuria". Pediatrics. 44 (4): 590–3. PMID 4899625.
  3. Rogers PW, Kurtzman NA, Bunn SM, White MG (February 1973). "Familial benign essential hematuria". Arch. Intern. Med. 131 (2): 257–62. PMID 4682986.
  4. Hostikka SL, Eddy RL, Byers MG, Höyhtyä M, Shows TB, Tryggvason K (February 1990). "Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome". Proc. Natl. Acad. Sci. U.S.A. 87 (4): 1606–10. doi:10.1073/pnas.87.4.1606. PMC 53524. PMID 1689491.
  5. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K (June 1990). "Identification of mutations in the COL4A5 collagen gene in Alport syndrome". Science. 248 (4960): 1224–7. doi:10.1126/science.2349482. PMID 2349482.
  6. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schröder CH, Smeets HJ (September 1994). "Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome". Nat. Genet. 8 (1): 77–81. doi:10.1038/ng0994-77. PMID 7987396.
  7. Lemmink HH, Nillesen WN, Mochizuki T, Schröder CH, Brunner HG, van Oost BA, Monnens LA, Smeets HJ (September 1996). "Benign familial hematuria due to mutation of the type IV collagen alpha4 gene". J. Clin. Invest. 98 (5): 1114–8. doi:10.1172/JCI118893. PMID 8787673.

Template:WH Template:WS